TSC | Jotup

VIQ Solutions Receives SOC 2 Type 1 Report in Major Step Forward Toward Full SOC 2 Compliance

Retrieved on:

Wednesday, April 3, 2024

The Company's SOC2 Type 1 report was issued by AssuranceLab, an independent and accredited certification body based in Australia, upon successful completion of a formal audit process.

Key Points:

The Company's SOC2 Type 1 report was issued by AssuranceLab, an independent and accredited certification body based in Australia, upon successful completion of a formal audit process.
Our SOC 2 Type 1 is a milestone pillar in our security program at VIQ, underlying the advanced and market leading maturity of the security controls of our information security systems.
"We are extremely proud to announce our SOC2 certification," said Vahram Sukyas, Chief Technology Officer, VIQ Solutions.
Our successful attainment of SOC2 Type 1 criteria and controls has set the groundwork for SOC2 Type 2 certification, which we intend to pursue in 2024.

The Shareholder Commons Publishes Portfolios on the Ballot 2024, an Investor Guide to Systems-First Proxy Voting

Retrieved on:

Wednesday, March 20, 2024

Professional Services, Environmental, Social and Governance (ESG), Environment, Technology, Environmental Issues, Finance, Artificial Intelligence, Intelligence, TSC, Meta, Sick leave, GOOG, GOOGL, Ballot, Security (finance)

Portfolios on the Ballot flags initiatives designed to protect the social and environmental systems that support all the companies in a diversified portfolio.

Key Points:

Portfolios on the Ballot flags initiatives designed to protect the social and environmental systems that support all the companies in a diversified portfolio.
In conjunction with the launch, TSC will hold a three-part webinar series starting on March 26th to highlight issues on the ballot and discuss how diversified investors can protect the value of their diversified portfolios this proxy season.
“This year, we have collected dozens of shareholder initiatives that aim to protect diversified investors’ common interests in protecting the systems that underlie a thriving economy,” says Rick Alexander, the CEO of The Shareholder Commons.
Portfolios on the Ballot highlights the ability of investors to steward the systems upon which the economy depends in the 2024 proxy season.

Major Teqball extravaganza descends upon Tulsa

Retrieved on:

Friday, April 5, 2024

Titan, TSC, Tourism, International Teqball Federation, Athlete, Pleasure, FITEQ, Entertainment

TULSA, Okla., April 5, 2024 /PRNewswire/ -- Tulsa, Oklahoma, has been chosen as the exclusive host city for this year's only Teqball event in the United States. The one-of-a-kind sporting spectacle that will combine the thrill of Teqball with the vibrant energy of Tulsa will be held from June 14 to 16. Although the action will take place in Tulsa, the energy certainly won't stop at the city limits as international TV and media will be onsite amplifying the tournament through a global broadcast.

Key Points:

The one-of-a-kind sporting spectacle that will combine the thrill of Teqball with the vibrant energy of Tulsa will be held from June 14 to 16.
After 2023, which was the busiest year for the Budapest, Hungary-based International Teqball Federation including six events in Los Angeles and one in Miami, the governing body of Teqball together with Tulsa Sports Commission will organize the only tour in the U.S. in northeast Oklahoma's premier destination.
"We are honored to be the only city in the country to host this unique event," Tulsa Mayor G.T.
"I am thankful to the Tulsa Sports Commission and so many others who are working to make Tulsa the city of choice for premiere sporting events."

TSC Alliance® Announces 23rd Annual Step Forward to Cure TSC®

Retrieved on:

Monday, April 1, 2024

TSC, Epilepsy, Step Forward, Brain, Disease, Seizure, Neoplasm, Research, Tuber, Quality of life, Life, Skin, Heart, Spectrum, DSM-IV codes, Fisher

SILVER SPRING, Md., April 1, 2024 /PRNewswire/ -- As part of its 50th anniversary activities, the TSC Alliance® will present its 23rd Annual Step Forward to Cure TSC® event series, which will take place between April 13 and May 19. Nobelpharma is the 2024 Title Sponsor.

Key Points:

SILVER SPRING, Md., April 1, 2024 /PRNewswire/ -- As part of its 50th anniversary activities, the TSC Alliance ® will present its 23rd Annual Step Forward to Cure TSC ® event series, which will take place between April 13 and May 19.
Proceeds will benefit the TSC Alliance's research efforts to find new treatments for tuberous sclerosis complex (TSC) and to offer an array of support programs and services.
"Each year, our Step Forward to Cure TSC events offer easy opportunities to support our cause," explained Kari Luther Rosbeck, TSC Alliance President & CEO.
"The TSC Alliance's Step Forward to Cure TSC campaign offers a fun and healthy way for anyone to have a positive impact on achieving that goal.

Computer Guidance Corporation Successfully Passes SOC 1 Type II and SOC 2 Type II Audits

Retrieved on:

Thursday, March 28, 2024

Cloud, TSC, SOC, Certified Public Accountant, Content management system, AICPA, Risk management, Type 2, Construction, Associated, CliftonLarsonAllen, ERP, LLP, Internet, American Institute, Confidentiality

SCOTTSDALE, Ariz., March 28, 2024 /PRNewswire-PRWeb/ -- Computer Guidance Corporation, the leading developer of cloud-based ERP solutions for the construction industry, today announced receipt of its annual System and Organization Control (SOC) SOC 1 Type II and SOC 2 Type II attestation engagement reports for the eCMS Hosting Service system that was designed and implemented throughout the period January 1, 2023, to December 31, 2023.

Key Points:

Computer Guidance Corporation Successfully Passes SOC 1 Type II and SOC 2 Type II Audits For Its Cloud Hosting Systems, Services, and Associated Processes Assurance provided by CliftonLarsonAllen, LLP in Accordance with Attestation Standards Established by the American Institute of Certified Public Accountants
SCOTTSDALE, Ariz., March 28, 2024 /PRNewswire-PRWeb/ -- Computer Guidance Corporation, the leading developer of cloud-based ERP solutions for the construction industry, today announced receipt of its annual System and Organization Control (SOC) SOC 1 Type II and SOC 2 Type II attestation engagement reports for the eCMS Hosting Service system that was designed and implemented throughout the period January 1, 2023, to December 31, 2023.
The audits reviewed several processes and procedures that have been implemented by Computer Guidance to proactively manage the cloud environments that host the eCMS system, associated Tier III data centers.
"Computer Guidance Corporation's successful completion of both SOC 1 Type II and SOC 2 Type II attestations demonstrates its integrity, accountability, and commitment to its clients, partners, and industry.
Computer Guidance customers can be confident that controls described within the report are accurately depicted and were operating as represented during these engagement periods."

AEOVIAN PHARMACEUTICALS DOSES FIRST PARTICIPANTS IN PHASE 1 CLINICAL TRIAL, STRENGTHENS LEADERSHIP TEAM AND RAISES ADDITIONAL $50 MILLION FINANCING

Retrieved on:

Thursday, March 28, 2024

BERKELEY, Calif., March 28, 2024 /PRNewswire/ -- Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel and highly selective therapeutics that potently inhibit the mTORC1 pathway, today announced that it has dosed the first cohort of participants in a Phase 1 clinical trial for its lead development candidate AV078, a first-in-class CNS penetrant selective mTORC1 inhibitor. Supporting this transition into the clinic, the company has also expanded its leadership team with the appointment of seasoned industry veterans William Greene, M.D., Chief Investment Officer at Hevolution, and Justin Gover, former Chief Executive Officer of GW Pharmaceuticals, to the company's Board of Directors, and appointed Micah Zajic as Chief Financial Officer. The company also recently completed a $50 million financing, led by Hevolution.

Key Points:

Aeovian has assembled a compelling platform for the development of selective mTORC1 inhibitors," said Dr. Greene, CIO at Hevolution.
In the $50M financing, Hevolution was joined by existing investors Apollo Health Ventures, Sofinnova Investments, venBio, Evotec and b2venture.
This financing will support the completion of the Phase 1 clinical trial in healthy volunteers and prepare for the start of a subsequent Phase 2 clinical trial in adult and pediatric patients with TSC refractory epilepsy.
As CEO, he built and led Iconic Therapeutics through discovery, clinical development, and venture financing, which culminated in a successful sale of the company.

Kazia Therapeutics licenses paxalisib to Sovargen for intractable seizures in rare central nervous system diseases

Retrieved on:

Thursday, March 21, 2024

TSC, PI3K, TSC1, Epilepsy, Brain, FCD, Central nervous system, Patient, CNS, Seizure, KZIA, TSC2, Pharmaceutical industry

Paxalisib is an oral dual inhibitor targeting both PI3K and mTOR within this pathway, and it is distinguished by its ability to penetrate the brain.

Key Points:

Paxalisib is an oral dual inhibitor targeting both PI3K and mTOR within this pathway, and it is distinguished by its ability to penetrate the brain.
Although FCD T2 and TSC are rare orphan diseases, they represent a high medical unmet need with significant market opportunity.
The licensing agreement includes all countries worldwide, excluding mainland China, Hong Kong, Macao and Taiwan, which Kazia retains.
Our license with Sovargen provides us the ability to explore the impact of paxalisib outside of our area of expertise where there is substantial patient need and market opportunity.

TSC Alliance® to Host 23rd Annual Comedy for a Cure® on April 14 in Los Angeles

Retrieved on:

Friday, March 15, 2024

LOS ANGELES, March 15, 2024 /PRNewswire/ -- Today, the TSC Alliance ® announced its 23nd Annual Comedy for a Cure ® will be held Sunday, April 14, at the historic Vibiana in Los Angeles.

Key Points:

LOS ANGELES, March 15, 2024 /PRNewswire/ -- Today, the TSC Alliance ® announced its 23nd Annual Comedy for a Cure ® will be held Sunday, April 14, at the historic Vibiana in Los Angeles.
"Every year, Comedy for Cure helps our organization raise significant funds to further TSC research, offer expanded support programs and increase awareness about the disease," said Kari Luther Rosbeck, TSC Alliance President & CEO.
"Over the years, this signature event has raised almost $6 million cumulatively to help improve the lives of everyone affected by TSC."
Comedy for a Cure also offers the opportunity to pay tribute to those who have made significant impacts in the right against TSC.

NaturVet welcomes Phil Bramel as Chief Commercial Officer

Retrieved on:

Wednesday, March 13, 2024

TSC, Target, Growth, Central Florida, PetSmart, University of Central Florida, Boehringer Ingelheim, University, CCO, Walmart, Family, Marketing, Warner–Lambert, J&J

TEMECULA, Calif, March 13, 2024 /PRNewswire-PRWeb/ -- NaturVet, the 30-year pioneer and present-day innovator of the pet health and wellness industry, is pleased to announce Phil Bramel as its new Chief Commercial Officer (CCO). Bramel brings a wealth of retail and sales expertise to the NaturVet family, with an illustrious 36-year career in various leadership roles within the pet health and wellness sector at companies such as Warner-Lambert, Pfizer, J&J, and Boehringer-Ingelheim. In his new role, Bramel will be responsible for driving sales and marketing strategies for NaturVet, including an expansion of the innovative brand's retail presence.

Key Points:

In his new role, Bramel will be responsible for driving sales and marketing strategies for NaturVet, including an expansion of the innovative brand's retail presence.
"It is with great enthusiasm that we introduce Phil Bramel as our Chief Commercial Officer," said Geoff Granger , the CEO of The Garmon Corporation and NaturVet.
Click to Post: @NaturVet announces Phil Bramel as the new Chief Commercial Officer.
"It is an honor to join the NaturVet family, particularly at a time when the company stands poised for significant growth," said Bramel.

A Forward-Looking Exploration of Wi-Fi: WAA - Informa Tech 2024 Barcelona Roundtable Concludes Successfully

Retrieved on:

Monday, March 4, 2024

David Mudd, Global Head of Digital Trust Assurance of BSI, emphasized the importance of AI in improving network security and experience.

Key Points:

David Mudd, Global Head of Digital Trust Assurance of BSI, emphasized the importance of AI in improving network security and experience.
Shi Hao, WAA Deputy Secretary-General, believes that home and campus scenarios are complex, with a multitude of technological options available.
To view an enhanced version of this graphic, please visit:
The roundtable concluded successfully in an atmosphere of joint cooperation and in-depth discussion.
This roundtable was not only WAA's first international seminar held overseas, but also a deep exploration and cooperative opportunity regarding the development direction of the Wi-Fi industry.